Dr. Kevin James Croce, MD, PhD

Dr. Croce practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Croce's NPI, 1417983172, was assigned on June 24, 2006. Dr. Croce graduated from Tufts University School of Medicine in 2001. Dr. Croce holds Massachusetts license 220516.

Dr. Croce's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Croce's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Croce is also affiliated with Newton-Wellesley Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Croce to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Croce practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Croce's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Croce is licensed in Massachusetts.

CMS data shows 539 Medicare services from Dr. Croce across 17 procedure codes in 2024, for 181 Medicare patients. Medicare paid $88,748 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 181 Medicare patients who saw Dr. Croce in 2024. The largest group is 75 to 84, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Croce's median patient age at 75, with 22% women.

In 2024, Dr. Croce wrote 247 Medicare Part D claims for 33 patients. 86% of them were for generic drugs. CMS names the drug for 182 of them, across 7 drugs with 11 or more claims each, at $24,824 in total drug cost. In 2023, CMS named 157 claims across 5 drugs.

Dr. Croce accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Croce as offering telehealth. CMS counts 126 procedures of coronary angioplasty and stenting by Dr. Croce, more than 98% of the clinicians it reports for that procedure.

CMS Open Payments shows 1,523 general payments to Dr. Croce from 33 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Abbott Laboratories paid the most, $949,113. It also lists 2 research payments totaling $7,250 from 2023 to 2025.

Dr. Croce graduated from Tufts University School of Medicine in 2001.